Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO Gross Margin

The Gross Margin of Neogenomics Inc (NEO) is 43.92%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

NEO Gross Margin - Historical Value
Date Value
2024-12-31 43.92%
2023-12-31 41.34%
2022-12-31 36.86%
2021-12-31 38.63%
2020-12-31 41.83%
2019-12-31 48.14%
2018-12-31 46.01%
2017-12-31 42.45%
2016-12-31 42.32%
2015-12-31 43.89%
NEO Gross Margin - Peers Comparison